Access to atrial flow regulators for implantation in critically ill children via the US Food and Drug Administration's emergency use pathway
{{output}}
Objectives: The authors conducted a review of the US Food and Drug Administration's (FDA) emergency use authorization (EUA) pathway as a mechanism to use the Occlutech Atrial Flow Regulator (AFR) (Occlutech International AB) for... ...
